Biovica International AB (OSTO:BIOVIC B) EV-to-EBIT : -0.45 (As of May. 26, 2024)

View and export this data going back to 2017. Start your Free Trial

What is Biovica International AB EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Biovica International AB's Enterprise Value is kr53.61 Mil. Biovica International AB's EBIT for the trailing twelve months (TTM) ended in Jan. 2024 was kr-119.91 Mil. Therefore, Biovica International AB's EV-to-EBIT for today is -0.45.

The historical rank and industry rank for Biovica International AB's EV-to-EBIT or its related term are showing as below:

OSTO:BIOVIC B' s EV-to-EBIT Range Over the Past 10 Years
Min: -41.61 Med: -9.33 Max: -0.03
Current: -0.45

During the past 9 years, the highest EV-to-EBIT of Biovica International AB was -0.03. The lowest was -41.61. And the median was -9.33.

OSTO:BIOVIC B's EV-to-EBIT is ranked worse than
100% of 426 companies
in the Biotechnology industry
Industry Median: 10.295 vs OSTO:BIOVIC B: -0.45

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Biovica International AB's Enterprise Value for the quarter that ended in Jan. 2024 was kr121.52 Mil. Biovica International AB's EBIT for the trailing twelve months (TTM) ended in Jan. 2024 was kr-119.91 Mil. Biovica International AB's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jan. 2024 was -98.67%.

Biovica International AB EV-to-EBIT Historical Data

The historical data trend for Biovica International AB's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biovica International AB EV-to-EBIT Chart

Biovica International AB Annual Data

Trend

Apr15

Apr16

Apr17

Apr18

Apr19

Apr20

Apr21

Apr22

Apr23

EV-to-EBIT

Get a 7-Day Free Trial

-8.25

-11.00

-25.63

-13.83

-2.05

Biovica International AB Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
EV-to-EBIT	Get a 7-Day Free Trial															-2.96	-2.05	-2.63	-0.62	-1.01

Competitive Comparison of Biovica International AB's EV-to-EBIT

For the Biotechnology subindustry, Biovica International AB's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biovica International AB's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Biovica International AB's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Biovica International AB's EV-to-EBIT falls into.

Biovica International AB EV-to-EBIT Calculation

Biovica International AB's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	53.608	/	-119.913
	=	-0.45

Biovica International AB's current Enterprise Value is kr53.61 Mil.
Biovica International AB's EBIT for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-119.91 Mil.

Biovica International AB (OSTO:BIOVIC B) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Biovica International AB's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jan. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Jan. 2024 )	=	EBIT	/	Enterprise Value (Q: Jan. 2024 )
	=	-119.913	/	121.52456
	=	-98.67 %

Biovica International AB's Enterprise Value for the quarter that ended in Jan. 2024 was kr121.52 Mil.
Biovica International AB's EBIT for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-119.91 Mil.

Biovica International AB EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Biovica International AB's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Biovica International AB (OSTO:BIOVIC B) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biovica International AB (OSTO:BIOVIC B) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

9II:Germany

Address

Dag Hammarskjolds vag 54B, Uppsala Science Park, Uppsala, SWE, 752 37

Website

http://www.biovica.com

Biovica International AB is a biotech company. It develops and commercializes blood-based diagnostic tests with biomarkers that improve monitoring and evaluation of modern cancer treatments. Through collaboration with world- leading cancer institutes and pharmaceutical companies, it promotes the trend in healthcare for personalized treatment, with a primary focus on patient survival and benefits to society. DiviTum is manufactured by the company and sold as a kit consisting of a reaction plate with reagents that have been optimized for ELISA applications.

Biovica International AB (OSTO:BIOVIC B) Headlines

No Headlines